[Tenofovir amibufenamide combined with pegylated interferon α-2b in treatment of chronic hepatitis B patients with low-level viremia: a case report].
Year: 2024
Type: article
Study design: Case Report
Abstract: 随着HBV DNA检测技术的发展，临床上慢性乙型肝炎（CHB）患者中低病毒血症的情况越来越常见，对于低病毒血症的抗病毒治疗方案选择是目前临床的难点和热点问题。艾米替诺福韦（TMF）临床用药的相关报道较少。该病例是1例低病毒血症的CHB患者应用TMF联合聚乙二醇干扰素α-2b（PEG-IFN-α-2b）治疗，实现了临床治愈，显著降低了肝癌的发生风险。在治疗过程中，观察到该患者应用TMF能快速抑制病毒复制，且安全性良好。对于追求临床治愈的CHB患者来说，TMF联合PEG-IFN-α-2b是一个新的可靠选择。.
Source: PubMed
Authors: D X He, S L Ma
Language: English
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4407800664